Perspective Therapeutics Inc (CATX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 48,488 | 53,972 | 30,629 | 26,762 | 28,849 |
| Marketable Securities | 188,388 | 216,957 | 114,108 | 147,375 | 162,729 |
| Receivables | 269 | 58 | 6 | 179 | 225 |
| TOTAL | $241,523 | $275,352 | $148,389 | $178,500 | $195,958 |
| Non-Current Assets | |||||
| PPE Net | 107,797 | 92,483 | 76,597 | 64,351 | 62,599 |
| Intangibles | 40,000 | 40,000 | 40,000 | 50,000 | 50,000 |
| Other Non-Current Assets | 2,705 | 2,934 | 1,986 | 1,974 | 2,168 |
| TOTAL | $150,502 | $135,417 | $118,583 | $116,325 | $114,767 |
| Total Assets | $392,025 | $410,769 | $266,972 | $294,825 | $310,725 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 29,418 | 26,485 | 20,511 | 13,148 | 7,048 |
| Accrued Expenses | 5,972 | 3,876 | 7,489 | 6,711 | 5,037 |
| TOTAL | $36,544 | $31,486 | $28,679 | $20,618 | $12,986 |
| Non-Current Liabilities | |||||
| Long Term Debt | 1,540 | 1,554 | 1,569 | 1,583 | 1,597 |
| Other Non-Current Liabilities | 1,776 | 1,989 | 1,391 | 1,313 | 1,355 |
| TOTAL | $31,618 | $31,845 | $31,262 | $31,991 | $32,047 |
| Total Liabilities | $68,162 | $63,331 | $59,941 | $52,609 | $45,033 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 114,152 | 114,046 | 113,933 | 74,338 | 74,263 |
| Common Shares | 114 | 114 | 74 | 74 | 74 |
| Retained earnings | -387,815 | -361,029 | -334,840 | -297,350 | -271,381 |
| Other shareholders' equity | -221 | -226 | 110 | 114 | 3 |
| TOTAL | $323,863 | $347,438 | $207,031 | $242,216 | $265,692 |
| Total Liabilities And Equity | $392,025 | $410,769 | $266,972 | $294,825 | $310,725 |